02/06/2009
TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
ReGen Therapeutics Plc
2. Reason for the notification:
An acquisition or disposal of voting rights
3. Full name of person(s) subject to the notification obligation (iii):
Barclays PLC
4. Full name of shareholder(s) (if difference from 3):
Barclays Stockbrokers Ltd
5. Date of the transaction and date on which the threshold is crossed or reached (v):
29th May 2009
6. Date on which issued notified:
2nd June 2009
7. Threshold(s) that is/are crossed or reached:
12% to 13%
8. Notified details
A: Voting rights attached to shares
| Class/type of share if possible using the ISIN Code | GB00B28XMY25 |
| Situation Previous to the triggering transaction (vi) - | |
| Number of Shares | 3,175,133 |
| Number of Voting Rights (viii) | 3,175,133 |
| Resulting situation after the triggering transaction (viii) - | |
| Number of Shares | 3,375,133 |
| Number of Voting Rights – Direct (x) | N/A |
| Number of Voting Rights – Indirect (xi) | 3,375,133 |
| % of voting rights – Direct | N/A |
| % of voting rights – Indirect | 13.22 |
B: Financial Instruments
| Resulting situation after the triggering transaction (xii) | |
| Type of financial instrument | N/A |
| Expiration date (xiii) | N/A |
| Exercise/Conversion Period/Date (xiv) | N/A |
| Number of voting rights that may be acquired if the instrument is exercised/converted | N/A |
| % of voting rights | N/A |
| Total (A+B) | |
| Number of voting rights | 3,375,133 |
| % of voting rights | 13.22 |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):
Barclays Stockbrokers Ltd
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
N/A
14. Contact name:
Geoff Smith
15. Contact telephone number:
0207 116 2913
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396